What is the share price of Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) today?
The share price of SOLARAPP1 as on 12th December 2025 is ₹406.85. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) share?
The past returns of Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) share are- Past 1 week: 15.65%
- Past 1 month: 2.44%
- Past 3 months: -8.67%
- Past 6 months: 17.65%
- Past 1 year: -13.22%
- Past 3 years: N/A%
- Past 5 years: 96.49%
What are the peers or stocks similar to Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1)?
The peers or stocks similar to Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) include:What is the 52 week high and low of Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) share?
The 52-week high of Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) is ₹511 and the 52-week low is ₹215.55.Which sector does Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) belong to?
Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) belongs to the Unknown sector & N/A sub-sector.How to buy Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) shares?
You can directly buy Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Solara Active Pharma Sciences Ltd Partly Paidup
SOLARAPP1 Share Price
406.853.13% (-13.15)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SOLARAPP1 Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
BadInsufficient Data
Red flags
LowNo red flag found
How to use scorecard? Learn more
SOLARAPP1 Performance & Key Metrics
SOLARAPP1 Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | — | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 0 | 0 | — |
SOLARAPP1 Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SOLARAPP1 Company Profile
Hmm, looks like data is unavailable here. Please come back after some timeSUNPHARMA
PE Ratio
39.37
39.37
1Y Return
0.66%
0.66%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.14
67.14
1Y Return
13.93%
13.93%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.25
23.25
1Y Return
4.98%
4.98%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.83
18.83
1Y Return
2.72%
2.72%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.43
29.43
1Y Return
0.28%
0.28%
Buy Reco %
72.22
72.22
SOLARAPP1 Sentiment Analysis
SOLARAPP1 Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
SOLARAPP1 Stock Summary · July 2025
In Q1 FY26, the company demonstrated robust financial performance with a 15% quarter-on-quarter revenue growth, reaching INR 320 crores, while maintaining a gross margin of 54%. Management is strategically pivoting away from overreliance on generic ibuprofen, focusing instead on complex derivatives and expanding into new markets to enhance profitability. Despite facing pricing pressures in certain segments, the commitment to operational efficiency and cost control remains strong, with an aim to sustain gross margins between 53% and 55%. Additionally, the company is actively reducing debt, targeting a net debt-to-EBITDA ratio of 1.5x, while investing in its CRAMS division to bolster future growth. Overall, the sentiment reflects cautious optimism, with expectations for EBITDA growth of 15% to 20% for the fiscal year.
SOLARAPP1 Stock Growth Drivers
SOLARAPP1 Stock Growth Drivers
5Strong Financial Performance
The company reported a robust Q1 FY '26 performance with a 15% quarter-on-quarter revenue growth,
Strategic Focus on Growth and Efficiency
The company is transitioning from a reset phase to a sustainable growth phase, emphasizing margin
SOLARAPP1 Stock Challenges
SOLARAPP1 Stock Challenges
3Debt Management Challenges
The company has reported a significant reduction in debt, achieving an 18% decrease from the
Market Competition and Pricing Pressures
The ibuprofen market is facing intense competition from new entrants, which has led to a
SOLARAPP1 Forecast
SOLARAPP1 Forecasts
Price
Revenue
Earnings
SOLARAPP1 Company Revenue Forecast
SOLARAPP1 Company Revenue Forecast
NaN
Current
₹—
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
NaN
Current
₹—
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
SOLARAPP1
SOLARAPP1
Income
Balance Sheet
Cash Flow
Annual Normal View
SOLARAPP1 Income Statement
SOLARAPP1 Income Statement
Annual Normal View
| Financial Year | TTM | |
|---|---|---|
| Total Revenue | — | |
Raw Materials | — | |
| Power & Fuel Cost | ||
| Employee Cost | ||
| Selling & Administrative Expenses | ||
| Operating & Other expenses | ||
EBITDA | — | |
| Depreciation/Amortization | — | |
| PBIT | — | |
| Interest & Other Items | — | |
| PBT | — | |
| Taxes & Other Items | — | |
| Net Income | — | |
| EPS | — | |
| DPS | — | |
| Payout ratio | — |
SOLARAPP1 Company Updates
SOLARAPP1 Stock Peers
SOLARAPP1 Past Performance & Peer Comparison
SOLARAPP1 Past Performance & Peer Comparison
Comparing 3 stocks from
UnknownPharmaceuticals
Compare valuation on Screener
UnknownPharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Solara Active Pharma Sciences Ltd Partly Paidup | — | — | — |
| Sun Pharmaceutical Industries Ltd | 39.37 | 5.94 | 0.89% |
| Torrent Pharmaceuticals Ltd | 67.14 | 16.91 | 0.84% |
| Cipla Ltd | 23.25 | 3.92 | 1.05% |
SOLARAPP1 Stock Price Comparison
Compare SOLARAPP1 with any stock or ETFCompare SOLARAPP1 with any stock or ETF
SOLARAPP1
SOLARAPP1 Holdings
SOLARAPP1 Shareholdings
SOLARAPP1 Promoter Holdings Trend
SOLARAPP1 Promoter Holdings Trend
No promoter holdings trend are available
SOLARAPP1 Institutional Holdings Trend
SOLARAPP1 Institutional Holdings Trend
No institutional holdings trend are available
SOLARAPP1 Shareholding Pattern
SOLARAPP1 Shareholding Pattern
Hmm, looks like data is currently unavailable. Once it's updated, you can view it hereSOLARAPP1 Shareholding History
SOLARAPP1 Shareholding History
Hmm, looks like data is currently unavailable. Once it's updated, you can view it hereHmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing SOLARAPP1 stock
smallcases containing SOLARAPP1 stock
Looks like this stock is not in any smallcase yet.
SOLARAPP1 Events
SOLARAPP1 Events
SOLARAPP1 Dividend Trend
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SOLARAPP1 Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SOLARAPP1 has not given any dividends in last 5 years
SOLARAPP1 Dividends
SOLARAPP1 Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSOLARAPP1 Stock News & Opinions
SOLARAPP1 Stock News & Opinions
Articles & Videos
Corporate
Solara Active PharmaSci.-PartlyPaidup AGM scheduled
Solara Active PharmaSci.-PartlyPaidup announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
1 year agoCapital Market - Live
SOLARAPP1 has not given any dividends in last 5 years